Magnesium sulphate infusion suppresses the cardiac release of noradrenaline during a handgrip stress test.

What Was Tested

Researchers studied Magnesium Sulfate in this randomized controlled trial publication.

To examine the effect of magnesium sulphate infusion on cardiac sympathetic efferent postganglionic neuronal liberation of noradrenaline.

Why It Was Studied

Magnesium has several important cardiovascular effects, but its effect on cardiac sympathetic efferent neuron activity has not been clarified.

Who Took Part

The age groups tagged for this paper are middle-aged adults and older adults, both men and women.

Twenty-two patients who underwent cardiac catheterization were randomly allocated to the control group or the magnesium group.

All patients were then subjected to 3 min of handgrip exercise stress test to augment sympathetic efferent neuronal activity, and the blood sampling was repeated.

How the Study Was Run

The design is described as randomized.

Random assignment meant chance, not the researchers, decided who got Magnesium Sulfate and who got the comparison, which limits bias.

Plasma noradrenaline and adrenaline concentrations in the aorta and the coronary sinus were measured.

Noradrenaline or adrenaline release from the heart was calculated by dividing the difference in noradrenaline or adrenaline concentration between the aorta and the coronary sinus by that of the aorta.

What Was Measured

Topics PubMed links to this paper include Analysis of Variance, Cardiac Catheterization, Coronary Disease, Epinephrine, Exercise Test, Hand Strength and Magnesium Sulfate.

What This Means in Plain Language

The paper is a randomized study of Magnesium Sulfate.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2002 (The Canadian journal of cardiology), a journal based in England.

More context: all human trials.